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Abstract
Family and twin studies of Borderline Personality Disorder (BPD) have found familial aggregation and genetic propensity
for BPD, but estimates vary widely. Large-scale family studies of clinically diagnosed BPD are lacking. Therefore, we
performed a total-population study estimating the familial aggregation and heritability of clinically diagnosed BPD. We
followed 1,851,755 individuals born 1973–1993 in linked Swedish national registries. BPD-diagnosis was ascertained
between 1997 and 2013, 11,665 received a BPD-diagnosis. We identiﬁed relatives and estimated sex and birth year adjusted
hazard ratios, i.e., the rate of BPD-diagnoses in relatives to individuals with BPD-diagnosis compared to individuals with
unaffected relatives, and used structural equation modeling to estimate heritability. The familial association decreased along
with genetic relatedness. The hazard ratio was 11.5 (95% conﬁdence interval (CI)= 1.6–83.8) for monozygotic twins; 7.4
(95% CI= 1.0–55.3) for dizygotic twins; 4.7 (95% CI= 3.9–5.6) for full siblings; 2.1 (95% CI= 1.5–3.0) for maternal half-
siblings; 1.3 (95% CI= 0.9–2.1) for paternal half-siblings; 1.7 (95% CI= 1.4–2.0) for cousins whose parents were full
siblings; 1.1 (95% CI= 0.7–1.8) for cousins whose parents were maternal half-siblings; and 1.9 (95% CI= 1.2–2.9) for
cousins whose parents were paternal half-siblings. Heritability was estimated at 46% (95% CI= 39–53), and the remaining
variance was explained by individually unique environmental factors. Our ﬁndings pave the way for further research into
speciﬁc genetic variants, unique environmental factors implicated, and their interplay in risk for BPD.
Introduction
Borderline personality disorder (BPD) is a complex psy-
chiatric disorder characterized by emotional dysregulation
[1, 2], severely impaired interpersonal functioning, and high
risk of suicide [3]. Prevalence estimates range from 0.5 to
5.9% [4, 5] with a median of approximately 1.6% [6].
The causes of BPD are poorly understood [6] but it has
been suggested to be associated with a low cognitive core
capacity related to emotional regulation, built up by multi-
ple sub-components that may be inﬂuenced both genetic
and environmental causes [1]. BPD aggregates in families
[7–16] but previous estimates of absolute risk in ﬁrst-degree
relatives range widely from 0.8% [15] to 18.3% [13].
Methodological differences, such as studying clinically
diagnosed BPD versus dimensions of BPD-traits, or ascer-
taining case status by clinical interview, self-rating ques-
tionnaire or indirectly by informants, most likely explain
much of the variability. Only one family study investigated
clinically diagnosed BPD in both individuals and
their relatives, and found an absolute risk of 14.1% in their
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ﬁrst-degree relatives, corresponding to a 3.9 times increased
risk compared to relatives of non-affected individuals [12].
However, the study population was at risk of selection bias
and the study did not report on sex differences. The latter
may be important, given the known female preponderance
of the diagnosis [17]. Critically, previous family studies of
BPD-diagnosis only included ﬁrst-degree relatives, and
could therefore not disentangle genetic from environmental
contributions to the observed familiality.
Twin and extended twin studies, including relatives of
twins, enable exploration of the relative contribution of
genetic and environmental factors to familial aggregation
[18]. Previous studies investigating the genetic impact of
BPD show widely ranging heritability estimates, from 0 to
72% [19–37]. Among the population-based studies only
seven ascertained case status by clinical interviews
[20, 29, 31–33, 35, 37] narrowing down heritability to 32 to
72%. However, all these studies were based on sub-
threshold BPD/BPD-traits and/or non-random selection of
participants.
In summary, due to heterogeneous assessment proce-
dures, questionable diagnostic validity, risk for biased
estimates, and underpowered studies due to small sample
sizes, there is considerable uncertainty regarding the
familiality and heritability of BPD. Further, it is unclear
how the results of many studies relate to clinically diag-
nosed BPD. To provide more precise and reliable estimates
of familial clustering and heritability of BPD, we conducted
a population-based familial aggregation study of more than
1.8 million individuals, including 11,665 individuals with
clinically diagnosed BPD. We also applied quantitative
genetic modeling in order to disentangle the genetic and
environmental contributions. In addition, we examined
possible sex differences in the patterns of familiality
of BPD.
Materials and methods
We performed a register linkage of the National Patient
Register (NPR) [38], the Multi-Generation Register (MGR)
[39], the Swedish Twin Registry (STR) [40], the Total
Population Register [41], the Cause of Death Register [42],
and the Medical Birth Register (MBR) [43]. The Regional
Ethical Review Board in Stockholm, Sweden, provided
ethical approval for the study (Dnr 2013/862–31/5). The
requirement of informed consent was waived since no
individual was contacted.
Study population
We identiﬁed 2,181,047 individuals born between 1973 and
1993 through the MBR. Individuals born with congenital
malformation (113,737), who died (9121) or emigrated
(190,047) before their 15th birthday or 1 Jan 1997, and
whose biological parents could not be identiﬁed (16,387),
were excluded. In all, our analytical sample comprised
1,851,755 individuals.
Using the MGR and the STR we identiﬁed all pairs of
following relatives types (degree of genetic relatedness, i.e.,
the average proportion of co-segregating alleles shared
between relatives, within brackets) monozygotic (MZ)
twins (100%), dizygotic (DZ) twins (50%), full siblings
(50%), maternal half-siblings (25%), paternal half-siblings
(25%), cousins whose parents were full siblings (12.5%),
and cousins whose parents were maternal half-siblings and
paternal half-siblings (6.25%). We paired every individual
with each relative of the different types that were identiﬁ-
able, the relative indexing the exposure and the individual
the outcome. Thus, each relative pair was included twice,
once with an individual as exposure person and once as
outcome person.
Study variables
Clinical diagnosis of BPD
We identiﬁed individuals with BPD using ﬁrst date of
International Classiﬁcation of Diseases 10th revision (ICD-
10) diagnoses for Emotionally Unstable Personality Disorder
(ICD-10 code F60.3) after their 15th birthday, in the NPR
from 1997 (when ICD-10 was introduced in Sweden). NPR
includes inpatient data throughout, and outpatient data from
2001. Our linkage was updated through 2013. In the Swedish
version of the ICD-10, the F60.3 diagnosis code corresponds
to the DSM-IV-TR criteria for BPD [44]. We have pre-
viously performed a medical chart validation study, showing
that 81% of investigated medical charts with F60.3 diagnosis
codes appropriately captured the DSM-IV-TR BPD-
diagnosis [45].
Covariates
To adjust for cohort effects, birth year was included as a
potential confounder and treated as a categorical variable
(1973–1977, 1978–1982, 1983–1987, 1988–1993). Fur-
thermore, to account for potential incidence and prevalence
differences between men and women, sex was included in
the analyses as a covariate.
Comorbidities
In addition, we identiﬁed ICD-10 diagnoses of psychiatric
disorders and self-harm from the NPR clustered into broad
groups (Table 1). The follow-up period was identical with
that for BPD and the diagnoses were treated as dichotomous
C. Skoglund et al.
variables (i.e., present or absent), regardless of when they
were recorded.
Statistical analyses
Descriptive
Number of individuals with and without a BPD-diagnosis
were calculated per sex, categorized birth year, half-sibling
status, and included comorbid disorders. We estimated
cumulative incidence for the full cohort, stratiﬁed per sex
and birth year, using a Kaplan-Meier approach.
Familial aggregation
Risk of BPD was estimated through Cox proportional
hazards regression, adjusted for sex and birth year of indi-
vidual and relative. We censored individuals at emigration,
death, or end of follow-up, whichever came ﬁrst. We
accounted for time during which a diagnosis was not
observable (i.e., prior to 1997 or age 15) by allowing
delayed entry into the at-risk group in analyses. Informed by
previous studies [46, 47] we used a time-varying exposure
approach; individuals were unexposed until the date of a
relative’s diagnosis, and exposed thereafter. Additionally,
we performed the analysis treating BPD as a binary vari-
able, ignoring time of follow-up, in logistic regressions.
Finally, again viewing BPD as a binary variable, we esti-
mated concordance rates (the proportion of relatives of an
individual with BPD also having BPD) and tetrachoric
correlations.
Conﬁdence intervals were obtained using a cluster robust
sandwich estimator to adjust for non-independence between
relative pairs.
Quantitative genetic analysis
We used a quantitative genetic approach similar to previous
studies [46, 47], which is based on classical twin metho-
dology [48]. Brieﬂy, from each family we included only the
sibling pair with the shortest time between births from each
nuclear family of MZ twins, DZ twins, full siblings,
maternal and paternal half-siblings. We used the liability-
threshold model, where an underlying normally distributed
liability of disease is assumed. If an individual has the
diagnosis, the risk-liability is assumed to be over an esti-
mated threshold. The inferred correlation between liabilities
in relatives is equivalent to a tetrachoric correlation, and the
basis for the quantitative genetic model. We estimated the
additive genetic effects (A), i.e., how different alleles of
Table 1 Descriptive, number of
individuals (column percent)
Not BPD BPD ICD-10 codes
N (row percent) 1,840,090 (99.4) 11,665 (0.6) NA
Sex
Male 953,487 (51.8) 1699 (14.6) NA
Female 886,603 (48.2) 9966 (85.4) NA
Birth year
1973–1977 419,606 (22.8) 2208 (18.9) NA
1978–1982 385,725 (21.0) 2826 (24.2) NA
1983–1987 410,953 (22.3) 3343 (28.7) NA
1988–1993 623,806 (33.9) 3288 (28.2) NA
Having a half-sibling 534,361 (29.0) 5543 (47.5) NA
Comorbiditiesa
Anxiety disorders 107,264 (5.8) 8836 (75.7) F40-F42, F43.1
Affective disorders 107,169 (5.8) 8864 (76.0) F30-F39
Substance use disorders 81,583 (4.4) 5672 (48.6) F10-F16, F18-F19
Psychotic disorders 11,526 (0.6) 1401 (12.0) F20-F29
Neurodevelopmental disorders 57,116 (3.1) 3625 (31.1) F70-F79, F84, F90, F95
Conduct disorders 3172 (0.2) 317 (2.7) F91
Eating disorders 17,188 (0.9) 2114 (18.1) F50
Personality disorders 15,898 (0.9) 4856 (41.6) F60-F69, excluding F60.3
Any of above psychiatric disorders 207,861 (11.3) 11,169 (95.7) Any of above
Self-harm 55,583 (3.0) 6063 (52.0) X60-X84, Y10-Y34
NA not applicable. All variables are statistically signiﬁcantly different between Not BPD and BPD group
according to Pearson χ2-tests, with p-values < 0.001
aIn Supplemental eTable 4 the included disorder codes are explained in more detail
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various loci affect the phenotypic outcome independently
and additively, also known as narrow sense heritability, on
the variance of the disorder. Additive genetic factors were
assumed shared 100% between MZ twins (as they are
genetically identical), 50% between full siblings and DZ
twins, and 25% between half-siblings. Further, we esti-
mated dominance deviations (D), the deviation from addi-
tive genetic effects due to interactions within genetic loci.
Dominance effects were assumed shared 100% between MZ
twins, 25% between full siblings and DZ twins, and 0%
between half-siblings. We also calculated the broad-sense
heritability (A+D), reﬂecting the total variance due to
genetic inﬂuences. We estimated shared family environ-
mental effects (C), i.e., environmental inﬂuences that have
the effect of making siblings more similar to one another,
such as socioeconomic status, religious beliefs in the family,
or parental rearing style. Similar to previous studies
[46, 47], we assumed that C was shared to an equal extent in
all siblings except paternal half-siblings. Finally, we esti-
mated individually unique environmental effects (E), which
are not shared between relatives, such as experiencing a
medical condition or sexual abuse. We ﬁtted the full model,
referred to as the ADCE-model, and compared the goodness
of ﬁt of reduced models (ACE, ADE, DCE, AE, CE, DE,
and E), using likelihood ratio tests. We also used Akaike’s
Information Criterion (AIC) for model comparisons, which
favors model parsimony and allows for comparison across
non-nested models. We adjusted the prevalence for sex,
birth year (in categories), and being a half-sibling.
We used the statistical software R and packages survival
[49], drgee [50], polycor [51], and OpenMx [52] for
analyses.
Sensitivity analyses
For full siblings, we performed the familial aggregation
analyses separately for sex-combinations of exposure and
outcome individuals, as well as separately per birth year
categories.
Among females only, we calculated concordance rates
and tetrachoric correlations for female siblings in a sub-
sample identiﬁed equivalently as outlined above. Finally,
we performed quantitative genetic analysis on females only
using the same subsample.
Results
Descriptive
Table 1 shows that more females than males were diag-
nosed with BPD (1.1% versus 0.2%). BPD-diagnosis was
less common in the oldest and youngest birth cohorts. The
amount of comorbid disorders was high: 95.7% of indivi-
duals with BPD-diagnosis had at least one of the other
included psychiatric diagnoses, compared to 11.3% in non-
BPD individuals, and all included disorder groups were
more prevalent among individuals with BPD. The most
common comorbidities were anxiety disorders (75.7%),
affective disorders (76.0%), and substance use disorders
(48.6%). We have previously reported that 30.9% of indi-
viduals with BPD-diagnosis also has a diagnosis of Atten-
tion-Deﬁcit/Hyperactivity Disorder [45]; in the current
study 31.1% of BPD-diagnosed also had a neurodevelop-
mental disorder diagnosis. Self-harm diagnoses were
common in BPD (52.0%), indicating that approximately
half of those with BPD presented self-mutilating behaviors
to the extent that they had received medical attention for
their self-harm.
The cumulative incidence of BPD was approximately
0.5% (0.8% in females and 0.2% in males) by age 25 and
increased to over 1% (almost 2% in females, and about
0.4% in males) by age 40 (Fig. 1). However, following
further stratiﬁcation by birth categories (Supplemental eFi-
gure 1), the importance of calendar periods of follow-up
became evident; showing the steepest increase in the
youngest cohort, were follow-up in younger years was
conducted in the most recent time period.
Familial aggregation
Results of familial aggregation calculated through Cox
regression are presented in Fig. 2 (Supplemental eTable 1
presents crude associations, and number of individuals and
pairs included in analyses). Overall, the associations
decreased along with decreasing genetic relatedness; MZ
twins had an adjusted hazard ratio (HR) of 11.5 (95%
conﬁdence interval (CI)= 1.6–83.8), while the HR for DZ
twins was 7.4 (95% CI= 1.0–55.3), and for full siblings 4.7
(95% CI= 3.9–5.6). For maternal half-siblings the HR was
2.1 (95% CI= 1.5–3.0), and for paternal half-siblings 1.3
(95% CI= 0.9–2.1) – a difference that was not statistically
signiﬁcant (p-value= 0.108). Cousins whose parents were
full siblings had a HR of 1.7 (95% CI= 1.4–2.0), for
cousins whose parents were maternal half-siblings it was
1.1 (95% CI= 0.7–1.8); and, for cousins whose parents
were paternal half-siblings the HR was 1.9 (95% CI=
1.2–2.9).
In Supplemental eTable 2 results from the logistic
regression analyses not taking follow-up time into account
are presented. The results adjusted for birth period did not
differ substantially from the main Cox-analyses.
Concordance rates and tetrachoric correlations in sub-
sampled pairs of siblings are presented in Table 2. Very few
twin pairs were concordantly diagnosed with BPD. The
concordance rate for full siblings was 2.5% (95% CI=
C. Skoglund et al.
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Meier estimates with 95%
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males in cohort
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Full siblings
Maternal half siblings
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Fig. 2 Familial aggregation. Hazard ratios (95% conﬁdence interval). Note: X-axis uses logarithmic scale; plot with non-logarithmic scale can be
found in Supplemental eFigure 2
Table 2 Concordances and tetrachoric correlations (95% conﬁdence interval)
Concordant without BPD Discordant BPD Concordant BPD Concordance ratea Tetrachoric correlation
MZ twins 3130 25 1 7.4% (−6.3–21.1) 0.45 (0.07–0.83)
DZ twins 3987 46 1 4.2% (−3.7–12.1) 0.30 (−0.06–0.66)
Full siblings 526,571 5936 76 2.5% (1.9–3.0) 0.21 (0.18–0.25)
Maternal half-siblings 63,313 1615 22 2.7% (1.6–3.7) 0.12 (0.05–0.19)
Paternal half-siblings 61,045 1545 16 2.0% (1.1–3.0) 0.08 (−0.01–0.16)
Data consists of the pairs born closest to each other, or one random pair if several born similarly close
aProportion of individuals with BPD-diagnosis whose relative also has BPD-diagnosis
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1.9–3.0), a 5-fold increase compared to the baseline pro-
portion of 0.5% among full siblings (see Table 1). Half-
siblings had similar concordance rates as full siblings,
however their baseline rate of diagnoses was higher (1.0%,
Table 1), and thus the concordance rate correspond to a 2 to
3-fold increase. The tetrachoric correlations decreased with
decreased genetic relatedness, from 0.45 in MZ twins to
0.08 in paternal half-siblings.
Quantitative genetic analysis
In Table 3 model ﬁtting results and estimates from quanti-
tative genetic analysis are presented. Compared to the
ADCE-model, reduced models yielded statistically non-
signiﬁcant decrease of model ﬁt for ACE, ADE, DCE, and
AE-models, and the AIC favored the AE model. In the AE-
model the heritability (A) was estimated at 46% (95% CI=
39–53), and non-shared environment (E) at 54% (95%
CI= 47–61).
Sensitivity analyses
In the analyses of familial aggregation among full siblings,
when one sex acted as both exposure and outcome indivi-
duals, males had a higher HR than females (11.6 versus 4.4,
p-value= 0.020; Supplemental eTable 3). However, the
support for sex differences did not permeate the analyses;
none of the other comparisons between exposure-outcome
combinations of sex was statistically signiﬁcant. For birth
years, the association was strongest for the oldest cohort,
and weakest for the cohort born 1983–1987 (Supplemental
eTable 3).
Among females, sibling concordance rates were higher,
reﬂecting the higher prevalence of the disorder among
women, but tetrachoric correlations did not differ con-
siderably from the main estimates (Supplemental eTable 5).
Consequently, quantitative genetic analysis on females only
yielded very similar result as the main analysis, with an
estimate of heritability of 47% (95% CI, 38–55) in the AE-
model (Supplemental eTable 6).
Discussion
This is the ﬁrst total-population study of familial aggrega-
tion and heritability of clinically diagnosed BPD. Con-
ﬁrming previous studies, relatives of individuals with a
diagnosis of BPD had a higher risk of receiving a BPD-
diagnosis than those without familial vulnerability. For
example, there was a 4.7 times increased risk for full
siblings. Heritability of clinically diagnosed BPD was
estimated at 46% (95% CI= 39–53), consistent with pre-
vious studies demonstrating the heritability of dimensionalTa
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BPD-traits in general population twin samples. The best
ﬁtting model indicated little or no role for shared familial
environmental factors. Thus, the pattern of familial aggre-
gation of BPD across different types of relatives indicates
that genetic factors play a signiﬁcant role in the risk of
developing BPD, and explain the familial clustering of the
disorder.
Previous heritability estimates vary widely [19–37] and
our results represent a substantial improvement in precision,
based on our sample size and the number of BPD-diagnosed
individuals, as reﬂected in the narrow conﬁdence intervals
for the heritability estimates. Furthermore, our ﬁndings
indicate that close family members of individuals represent
an important high-risk group for developing BPD; and that
this is due to genetic, and not environmental, inﬂuences.
This has important implications. Firstly, clinicians need to
be aware of the elevated risks for BPD in relatives of BPD-
patients. Secondly, although thus far no single nucleotide
polymorphism (genetic variant) have been identiﬁed that
reach genome-wide signiﬁcance [53, 54], future molecular
genetic studies may, given sufﬁcient sample sizes, identify
some of the genetic risk factors that confer risk for BPD.
The results also estimate a 54% contribution of non-
shared, individually unique, environmental factors. Shared
environment did not inﬂuence the statistical goodness of ﬁt,
suggesting that shared familial environmental factors, such
as socioeconomics, are unlikely to contribute substantially
to the etiological underpinnings of BPD. Traumatic life
events, such as sexual or physical abuse and parental
divorce or illness, are more frequently reported by indivi-
duals with BPD compared to healthy controls or patients
with other personality disorders [8, 55–58]. Although no
given environmental risk factor has yet to be clearly iden-
tiﬁed as causative, our ﬁndings suggest that these may
reﬂect unique environmental risks to individuals within a
family or might act via gene-by-environment interactions.
Further, these environmental associations could also reﬂect
gene-environment correlations, additionally complicating
the identiﬁcation of speciﬁc environmental risks. The
identiﬁcation of unique environmental risk factors and
gene-by-environment interactions for BPD should be
regarded a research priority, as these are potentially pre-
ventable or modiﬁable via early interventions.
In line with previous research, the pattern of comorbid
disorders showed that comorbidity is a hallmark of BPD.
One potential cause for high comorbidity rates is genetic
overlap since recent research ﬁndings indicate high genetic
overlap across many psychiatric disorders and a general
genetic propensity [59, 60]. Thus, our results are likely to
partly reﬂect non-speciﬁc genetic effects that acts across
mental health disorders. Here we did not adjust our analyses
for any comorbid conditions since adjustment would most
likely inﬂuence our results in a non-interpretable way.
On a mechanistic level, it has been suggested that
several underlying neural and cognitive processes
involved in emotional regulation are dysfunctional in
BPD [1]. The present study suggests that that these
underlying deﬁcits are largely genetically predetermined.
Such regulatory processes are thought to involve widely
distributed large-scale neural networks, including speciﬁc
prefrontal and anterior cingulate regions, networks
involved in emotional processing, basal ganglia circuits,
and neuromodulatory systems such as dopamine and
noradrenaline systems [1, 2].
Since we had categorical yes/no measure of BPD, we
necessarily treated it as a categorical variable in analyses,
rather than having continuous measures or separate symp-
toms. Concurrent research has found that many psychiatric
diagnoses are representable as the extreme end of a con-
tinuous trait [61], although no study speciﬁcally addressing
this in BPD has been performed. Further, recent research
supports a close association between categorical BPD-
criteria (i.e., BPD-symptoms) and corresponding trait
dimensions of personality disorders [62, 63]. Thus, BPD-
diagnoses, as used in current study, likely represent the
same underlying psychopathological construct as previous
work using symptoms and/or dimensional measures of
BPD-traits.
This study has several important strengths including
utilizing Swedish nationwide register linkages. Previous
studies are often limited by small sample sizes [7–10, 13–
16, 19, 34, 36] the use of BPD-traits rather than diagnosis
[7, 9, 10, 19–24, 28, 29, 31–33, 35–37, 64], and self-
rating questionnaires [16, 19, 21–28, 30] rather than
clinical diagnoses, exposing them to risks of low statis-
tical power, selection- and recall bias. This register-based
population cohort provided large sample-size, well-
identiﬁed biological relatives, extensive follow-up time,
and clinical diagnoses. Furthermore, data was gathered
consecutively and independently from the current study.
Moreover, previous studies investigating etiological
underpinnings of BPD are predominantly based on twins.
This study uses multiple types of relatives, and quantita-
tive genetic analysis was performed in a sibling sample.
Our results need to be interpreted in light of some lim-
itations. First, we most likely underestimate the true pro-
portion of individuals with symptom levels and
impairments corresponding to BPD-diagnosis (i.e., more
cases would be identiﬁed if everyone in the cohort was
assessed for BPD). Second, it is possible that we are
missing male individuals with BPD in our population
sample as the female to male ratio in our study is 5.5:1,
whereas a more even sex ratio has been reported in a US
community sample assessed by interview [4]. Results
remained stable in women, but we did not have sufﬁcient
power to perform the quantitative genetic analysis in men;
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thus, generalization of our ﬁndings to men with BPD should
be made with caution. Third, the BPD-diagnosis is based on
fulﬁlling at least ﬁve out of nine symptom criteria leading to
clinically signiﬁcant distress or functional impairment in
important life areas, and thus a substantial heterogeneity of
symptom proﬁles exists. Although heterogeneity may
hamper speciﬁcity of the diagnosis, our previous medical
chart validation study demonstrated the correspondence of
the register-based diagnoses with the DSM-IV criteria [45].
Further, identiﬁed individuals with a diagnosis of BPD in
our population comprise those in contact with the health
care system, thus representing the “real world” cases, and
are most likely a representative sample of individuals suf-
fering from functional impairment related to BPD-
symptoms. Fourth, our methods will not detect individuals
diagnosed in outpatient care prior to 2001. Importantly,
however, under-detection of BPD is likely to bias the esti-
mates towards the null. Fifth, relatives to individuals with a
BPD-diagnosis may be in closer contact with health care
and consequently be more likely to receive a diagnosis, thus
inﬂating the estimates due to detection bias. Sixth, BPD is
reported to be most prevalent in adolescence, and its pre-
valence decreases signiﬁcantly towards the age of 24 [19].
We detected different incidence rates of BPD across dif-
ferent calendar periods with an increased propensity of
assigning BPD-diagnosis at earlier ages, a phenomenon that
may indicate changes in diagnostic practice. The extended
twin/family design makes it less sensitive to trends in
diagnostic practice; if time or local trends are present they
are likely to apply to the population in a similar way. Lastly,
our follow-up periods started later in older cohorts. The
results might be affected by left truncation, missing earlier
onset BPD. However, BPD is often described as a disorder
of “stable instability” [6, 23, 55, 65, 66], resulting in
repeated interactions with health care, increasing the like-
lihood of being identiﬁed as carrying a diagnosis in the
current study.
In conclusion, BPD aggregates in families and the
heritability was estimated at 46%, with the remaining
variance explained by non-shared environmental factors.
This ﬁnding is important for further expanding our
understanding of BPD. The time is ripe for identiﬁcation
of genetic variants associated with BPD through large
scale genome-wide studies, for identiﬁcation of environ-
mental risk factors, and of how these correlate or interact
to increase the risk of BPD.
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